LC
DOCS icon

Lindbrook Capital’s Doximity DOCS Stock Holding History

Lindbrook Capital’s Portfolio DOCS Stock Details DOCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$38K Buy
655
+269
+70% +$17K ﹤0.01% 1112
2024
Q4 		$20.6K Sell
386
-7
-2% -$343 ﹤0.01% 1274
2024
Q3 		$17.1K Sell
393
-10
-2% -$334 ﹤0.01% 1380
2024
Q2 		$11.3K Buy
403
+180
+81% +$4.75K ﹤0.01% 1560
2024
Q1 		$6K Hold
223
– – ﹤0.01% 1818
2023
Q4 		$6.25K Buy
223
+183
+458% +$4.32K ﹤0.01% 1762
2023
Q3 		$849 Sell
40
-29
-42% -$792 ﹤0.01% 2399
2023
Q2 		$2.35K Buy
69
+9
+15% +$300 ﹤0.01% 2092
2023
Q1 		$1.94K Sell
60
-30
-33% -$995 ﹤0.01% 2257
2022
Q4 		$3.02K Buy
90
+83
+1,186% +$2.54K ﹤0.01% 2049
2022
Q3 		$0 Sell
7
-193
-97% -$7.07K ﹤0.01% 2682
2022
Q2 		$7K Buy
+200
New +$7.87K ﹤0.01% 1397

Other funds holding DOCS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Lindbrook Capital's DOCS Position: Q1 2025 in Review

Lindbrook Capital increased its Doximity (DOCS) stake by 70% in Q1 2025, buying an estimated $17K and bringing the position to 655 shares worth $38K. The position accounts for ﹤0.01% of the portfolio, ranked #1112.

Lindbrook Capital first reported a position in DOCS in Q2 2022 and has held it in 12 quarters since. 491 funds tracked by Wall St. Rank hold DOCS as of Q1 2025.

  • Lindbrook Capital held 655 shares of Doximity worth $38K as of Q1 2025.
  • Lindbrook Capital bought 269 Doximity shares in Q1 2025, an estimated $17K.
  • Doximity made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1112 holding.
  • Lindbrook Capital first reported a position in Doximity in Q2 2022 and has held it in 12 quarters since.
  • 491 funds tracked by Wall St. Rank held Doximity as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.